Cancer Detection Software
-
by Cortechs.aibased in USA
OnQ Prostate is FDA-cleared post-processing software that supports improved detection of clinically significant prostate cancer. Leveraging an advanced diffusion MRI technique called Restriction Spectrum Imaging, powered by AI, the software enables faster, more accurate PI-RADS ...
-
by Arterys Inc.based in USA
Breast AI provides innovative solutions for breast cancer detection, measure breast density and assess personalized risk that offer clinically proven benefits to clinicians and patients, and are designed to optimize efficiency, enhance the patient experience, and improve outcomes. ...
-
Manufactured by CMR Naviscan Corporationbased in USA
A New Standard of Care in Early Breast Cancer Detection. Even when a mammogram is deemed negative, additional adjunctive tests, such as Molecular Breast Imaging (MBI), for women with dense breast tissue or who are considered high-risk for breast cancer should be considered. When a patient is determined to have dense breast tissue, or ...
-
by Lunit Inc.based in SOUTH KOREA
Lunit INSIGHT MMG is all about breast cancer. Accurately detects lesions suspicious of breast cancer in a mammogram. Developed using Lunit’s cutting-edge deep learning ...
-
based in UNITED KINGDOM
in reducing technical recalls and delivering the high-quality images you need for accurate breast cancer detection. Read on to discover how Mia IQ helps to ensure compliance and standardise image quality. Mia IQ™ is registered with the FDA in the US. Mia IQ is available in the EU and UK. In-country product registrations required for other ...
-
by Lunit Inc.based in SOUTH KOREA
Lunit INSIGHT CXR covers the vast majority of findings. Accurately detects 10 of the most common findings in a chest x-ray. Developed by using Lunit’s cutting-edge deep learning ...
-
based in UNITED KINGDOM
Right now, there’s a huge problem that can’t be ignored. Across the globe, a staggering number of women missed their routine mammogram during the COVID-19 crisis, meaning that existing backlogs due to radiologist shortages and demanding workloads grew even higher. RSViP™ is our AI-enabled invitation tool that helps you effectively manage your backlog and quickly get back up to ...
-
based in UNITED KINGDOM
Mia, whose name comes from Mammography Intelligent Assessment, is our breakthrough AI platform for breast screening. A suite of solutions, Mia empowers radiologists and screening services to deliver confident, accurate and timely results to every woman, ...
-
based in USA
HALO Prostate AI, from Indica Labs, is a CE-IVD certified deep learning based screening tool designed to assist pathologists in the identification and grading of prostate cancer in core needle biopsies. The algorithm automatically analyzes all appropriate case slides and notifies pathologists of cases with suspected findings ...
-
based in UNITED KINGDOM
Mia® is our breakthrough AI platform for breast screening. A suite of solutions, Mia empowers radiologists and screening services to deliver confident, accurate and timely results to every woman, everywhere. Discover how Mia delivers gold-standard quality and performance for double reader triage, increasing efficiency by automating up to 25% of your reading workflow. Mia® Triage is part ...
-
based in USA
cmDensity An investigational, artificial intelligence- based triage software that helps radiologists classify density accurately and ...
-
based in USA
Hematological tumors represent the fourth most frequent cancer type in the developed world. In addition to the continuously evolving clinical guidelines2, harnessing of all the available information when investigating hematological disorders into meaningful insights can be outdated, inaccurate, costly, and time-consuming. This ultimately ...
-
based in USA
HALO AI is a collection of train-by-example classification and segmentation tools underpinned by advanced deep learning neural network algorithms. HALO AI classifiers can be trained to quantify tissue classes, to segment tissue classes for analysis with other HALO image analysis modules, to find rare events or cells in tissues, and to categorize cell populations into specific ...
-
based in USA
Hereditary causes account for ∼10% of cancer cases, and an estimated 20% of cancer patients have a family history of cancer. Identification of an individual with a suspected hereditable cancer can lead to additional examinations and help formulate the most appropriate prevention strategies. Evaluating the predisposition to ...
-
based in USA
Cancer diagnosis with ultrasound requires great vision. Koios uses artificial intelligence and machine learning to provide clinical decision support (“DS”) for physicians and technologists when using ultrasound to detect and diagnose cancer. The result: Smart Ultrasound™ Research continues to prove that physician ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you